TXN
35
5
NRG
39
4
TXT
48
2
SYK
57
6
NUE
41
2
ADSK
63
2
DOW
47
3
QRVO
20
2
CRM
67
2
MS
70
6
UNP
40
2
HPQ
57
2
EQT
48
6
HIG
51
4
ABBV
48
2
GLW
48
4
STX
37
2
GT
47
4
COP
39
5
MMC
50
4
TXN
35
5
NRG
39
4
TXT
48
2
SYK
57
6
NUE
41
2
ADSK
63
2
DOW
47
3
QRVO
20
2
CRM
67
2
MS
70
6
UNP
40
2
HPQ
57
2
EQT
48
6
HIG
51
4
ABBV
48
2
GLW
48
4
STX
37
2
GT
47
4
COP
39
5
MMC
50
4
Financhill
Back

Immuneering 10K Form

Buy
53

IMRX
Immuneering

Last Price:
$2.26
Seasonality Move:
-14.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMRX News And Ratings

See the #1 stock for the next 7 days that we like better than IMRX

IMRX Financial Statistics

Sales & Book Value

Annual Sales: $317K
Cash Flow: $-13.5M
Price / Cash Flow: 0
Annual Sales: $1.86
Price / Book: 1.21

Profitability

EPS (TTM): -1.97000
Net Income (TTM): $-58.1M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Immuneering Earnings Forecast

Key Immuneering Financial Ratios

  • The Selling, General & Administrative Expenses for IMRX have been equal to 4,924.12% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Immuneering Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMRX
Website: immuneering.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMRX Technical Analysis vs Fundamental Analysis

Buy
53
Immuneering (IMRX) is a Buy

Is Immuneering a Buy or a Sell?

  • Immuneering stock is rated a Buy
    The current Immuneering [IMRX] share price is $2.25. The Score for IMRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.